Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade.

Saved in:
Bibliographic Details
Title: Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade.
Authors: Deutsch JS; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lai J; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Schenk KM; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Soni A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Will EM; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Engle LL; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Xu H; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ogurtsova A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Madan V; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Chong JK; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wang D; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Green BF; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Nguyen P; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Schollenberger MD; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lipson EJ; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University, Baltimore, Maryland, USA., Taube JM; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jtaube1@jhmi.edu.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University, Baltimore, Maryland, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Dec 14; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 14.
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2023-007463